No large pharma company has traversed this decade's ups and downs quite like Pfizer. | No large pharma company has traversed ...

For the second time in 19 months, a federal judge in New York has dismissed a lawsuit claiming that Bristol Myers Squibb slow ...

Following a similar move in March, Pfizer is offloading another tranche of Haleon shares. | Pfizer has sold 640 million ...

Nonprofit heart health group the Family Heart Foundation has joined forces with Amgen for a new cholesterol health campaign.

Piramal Pharma Solutions, a unit of Indian CDMO Piramal Pharma, plans to spend $80 million to expand its sterile injectables ...

Phreesia has generated evidence that exposing patients to vaccine messages at the point of care boosts the vaccination rate, ...

Astellas Pharma is slowing things down in the inaugural consumer-facing marketing blast for eye disease drug Izervay. | ...

On Monday, SK revealed that it will spend $260 million to construct its fifth production site in its home country, this one ...

With its first approval in hand, privately held IntraBio is embarking upon the difficult task of marketing a drug for an ...

Moderna has suffered its second PMCPA rebuke in quick succession. Days after ruling Moderna had brought discredit on the ...

After experiencing a series of ups and downs in recent years, the biopharma contracting business is gearing up for a rebound ...

After putting on a strong performance in preventing disease progression in the earlier treatment of multiple myeloma, Johnson ...